Literature DB >> 14726576

Public health. A sound rationale needed for phase III HIV-1 vaccine trials.

Dennis R Burton1, Ronald C Desrosiers, Robert W Doms, Mark B Feinberg, Robert C Gallo, Beatrice Hahn, James A Hoxie, Eric Hunter, Bette Korber, Alan Landay, Michael M Lederman, Judy Lieberman, Joseph M McCune, John P Moore, Neal Nathanson, Louis Picker, Douglas Richman, Charles Rinaldo, Mario Stevenson, David I Watkins, Steven M Wolinsky, Jerome A Zack.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh：

Substances：

Year:  2004        PMID： 14726576     DOI： 10.1126/science.1094620

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  46 in total

Review 1.  Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative.

Authors:  Timothy J Tucker; Gatsha Mazithulela
Journal:  BMJ       Date:  2004-08-21

2.  Mining the mechanisms of an HIV vaccine.

Authors:  Stanley A Plotkin; Harriet L Robinson; Miles P Davenport
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 3.  Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV.

Authors:  George Makedonas; Michael R Betts
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

4.  HIV neutralizing antibodies: clinical correlates and implications for vaccines.

Authors:  Nicole A Doria-Rose
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

Review 5.  Current advances in HIV vaccines.

Authors:  M Patricia D'Souza; Mary Allen; Rebecca Sheets; Margaret I Johnston
Journal:  Curr HIV/AIDS Rep       Date:  2004-04       Impact factor: 5.071

Review 6.  HIV vaccines: lessons learned and the way forward.

Authors:  Jerome H Kim; Supachai Rerks-Ngarm; Jean-Louis Excler; Nelson L Michael
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

Review 7.  Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets.

Authors:  S Phogat; R T Wyatt; G B Karlsson Hedestam
Journal:  J Intern Med       Date:  2007-07       Impact factor: 8.989

Review 8.  T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces.

Authors:  Bette T Korber; Norman L Letvin; Barton F Haynes
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

9.  HIV: Design by trial.

Authors:  David V Glidden
Journal:  Nature       Date:  2012-10-18       Impact factor: 49.962

10.  Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.

Authors:  Scott A Brown; Sherri L Surman; Robert Sealy; Bart G Jones; Karen S Slobod; Kristen Branum; Timothy D Lockey; Nanna Howlett; Pamela Freiden; Patricia Flynn; Julia L Hurwitz
Journal:  Viruses       Date:  2010-02-01       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.